Updated overall efficacy and safety of selpercatinib in patients (pts) with RET fusion+ non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Besse, B.; Drilon, A. E.; Solomon, B. J.; Subbiah, V.; Tan, D. S. W.; Park, K.; De Braud, F. G.; Alonso, G.; Wolf, J.; Soldatenkova, V.; Lin, A. K.; French, P. P.; Goto, K.; Gautschi, O.
Abstract Title: Updated overall efficacy and safety of selpercatinib in patients (pts) with RET fusion+ non-small cell lung cancer (NSCLC)
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120605046
DOI: 10.1200/JCO.2021.39.15_suppl.9065
PROVIDER: wos
Notes: Meeting Abstract: 9065 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon